ATRAAtara Biotherapeutics, Inc.Nov 4, 2023Q3 2023
Read transcript →Atara Biotherapeutics, Inc. (ATRA)
NASDAQ·Healthcare·Biotechnology
$4.80
-3.91%
Mkt Cap $40.81M
ATRAAtara Biotherapeutics, Inc.Nov 4, 2023ATRAAtara Biotherapeutics, Inc.Nov 8, 2022Q3 2022
Read transcript →ATRAAtara Biotherapeutics, Inc.Aug 8, 2022Q2 2022
Read transcript →ATRAAtara Biotherapeutics, Inc.May 5, 2022Q1 2022
Read transcript →ATRAAtara Biotherapeutics, Inc.Feb 28, 2022Q4 2021
Read transcript →ATRAAtara Biotherapeutics, Inc.Nov 4, 2021Q3 2021
Read transcript →ATRAAtara Biotherapeutics, Inc.Aug 9, 2021Q2 2021
Read transcript →ATRAAtara Biotherapeutics, Inc.May 5, 2021Q1 2021
Read transcript →ATRAAtara Biotherapeutics, Inc.Mar 1, 2021Q4 2020
Read transcript →ATRAAtara Biotherapeutics, Inc.Nov 10, 2020Q3 2020
Read transcript →ATRAAtara Biotherapeutics, Inc.Aug 5, 2020Q2 2020
Read transcript →ATRAAtara Biotherapeutics, Inc.May 6, 2020Q1 2020
Read transcript →ATRAAtara Biotherapeutics, Inc.Feb 27, 2020Q4 2019
Read transcript →ATRAAtara Biotherapeutics, Inc.Nov 8, 2019Q3 2019
Read transcript →ATRAAtara Biotherapeutics, Inc.Aug 9, 2019Q2 2019
Read transcript →ATRAAtara Biotherapeutics, Inc.May 12, 2019Q1 2019
Read transcript →